Review presents synthesis and structure-activity relationships of pyrazoline derivatives, indicating their potential against antimicrobial resistance.
The escalating prevalence of antimicrobial resistance poses a severe global health threat, urging the scientific community to explore novel chemical entities with potent, broad-spectrum antimicrobial properties. Among various heterocyclic scaffolds, pyrazoline derivatives have attracted considerable interest due to their structural versatility and diverse pharmacological activities. This review systematically presents recent developments in the synthesis and structural-activity relationship (SAR) of pyrazoline-based compounds with proven antimicrobial efficacy. The synthesis of pyrazoline analogues primarily involves the cyclocondensation of chalcones with hydrazine derivatives, employing both conventional and modern techniques, such as microwave-assisted synthesis and green protocols. Structural modifications through the incorporation of various electronwithdrawing or electron-donating groups have been widely explored to enhance antimicrobial potential. Notably, substituents such as halogens, nitro, hydroxyl, methoxy, and alkyl chains have demonstrated significant influence on biological activity by improving cell permeability and interactions with microbial targets. Several derivatives show potent activity against both Gram-positive and Gram-negative bacteria, as well as fungi, often outperforming standard antimicrobial agents. Furthermore, SAR studies reveal that the position and nature of substituents on the aromatic ring play a crucial role in determining the selectivity and potency of the derivatives. This review provides valuable insights into how synthetic strategies and structural features influence antimicrobial activity, serving as a guide for rational design and optimization of future therapeutic agents. The findings reinforce the potential of pyrazoline scaffolds as a viable platform in combating microbial infections and multidrug-resistant organisms.
No takes yet. Share an insight, caveat, or question.
Datt et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: